Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 376

1.

Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era.

Chiao EY, Giordano TP, Richardson P, El-Serag HB.

J Clin Oncol. 2008 Jan 20;26(3):474-9. doi: 10.1200/JCO.2007.14.2810.

PMID:
18202423
2.

Outcome of HIV-infected patients with invasive squamous-cell carcinoma of the anal canal in the era of highly active antiretroviral therapy.

Stadler RF, Gregorcyk SG, Euhus DM, Place RJ, Huber PJ, Simmang CL.

Dis Colon Rectum. 2004 Aug;47(8):1305-9.

PMID:
15484343
3.

HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy.

Oehler-Jänne C, Huguet F, Provencher S, Seifert B, Negretti L, Riener MO, Bonet M, Allal AS, Ciernik IF.

J Clin Oncol. 2008 May 20;26(15):2550-7. doi: 10.1200/JCO.2007.15.2348. Epub 2008 Apr 21.

PMID:
18427149
4.

Outcome analysis of HIV-positive patients with anal squamous cell carcinoma.

Place RJ, Gregorcyk SG, Huber PJ, Simmang CL.

Dis Colon Rectum. 2001 Apr;44(4):506-12.

PMID:
11330577
5.

Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy.

Wexler A, Berson AM, Goldstone SE, Waltzman R, Penzer J, Maisonet OG, McDermott B, Rescigno J.

Dis Colon Rectum. 2008 Jan;51(1):73-81. Epub 2007 Dec 8.

PMID:
18066626
6.

A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic.

Chiao EY, Krown SE, Stier EA, Schrag D.

J Acquir Immune Defic Syndr. 2005 Dec 1;40(4):451-5.

PMID:
16280701
7.

Clinical presentation and outcome of squamous cell carcinoma of the anus in HIV-infected patients in the HAART-era: a GICAT experience.

Martellotta F, Berretta M, Cacopardo B, Fisichella R, Schioppa O, Zanghì A, Spartà D, Cappellani A, Talamini R, Izzi I, Ridolfo A, Torresin A, Fiorica F, Tirelli U.

Eur Rev Med Pharmacol Sci. 2012 Sep;16(9):1283-91.

8.

Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for invasive anal carcinoma in human immunodeficiency virus-positive patients receiving highly active antiretroviral therapy.

Fraunholz I, Weiss C, Eberlein K, Haberl A, Rödel C.

Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1425-32. doi: 10.1016/j.ijrobp.2009.03.060. Epub 2009 Sep 8.

PMID:
19744801
9.

Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.

Burgi A, Brodine S, Wegner S, Milazzo M, Wallace MR, Spooner K, Blazes DL, Agan BK, Armstrong A, Fraser S, Crum NF.

Cancer. 2005 Oct 1;104(7):1505-11.

10.

Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.

Grau I, Pallares R, Tubau F, Schulze MH, Llopis F, Podzamczer D, Liñares J, Gudiol F; Spanish Pneumococcal Infection Study Network (G03/103).

Arch Intern Med. 2005 Jul 11;165(13):1533-40.

PMID:
16009870
11.

Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection.

Butt AA, Fultz SL, Kwoh CK, Kelley D, Skanderson M, Justice AC.

Hepatology. 2004 Jul;40(1):115-9.

PMID:
15239093
12.

Survival in hepatitis C and HIV co-infection: a cohort study of hospitalized veterans.

El-Serag HB, Giordano TP, Kramer J, Richardson P, Souchek J.

Clin Gastroenterol Hepatol. 2005 Feb;3(2):175-83.

PMID:
15704052
13.

Human immunodeficiency virus-associated prostate cancer: clinicopathological findings and outcome in a multi-institutional study.

Pantanowitz L, Bohac G, Cooley TP, Aboulafia D, Dezube BJ.

BJU Int. 2008 Jun;101(12):1519-23. doi: 10.1111/j.1464-410X.2008.07474.x. Epub 2008 Apr 2.

14.

Epidermoid anal cancer prognosis comparison among HIV+ and HIV- patients.

Abramowitz L, Mathieu N, Roudot-Thoraval F, Lemarchand N, Bauer P, Hennequin C, Mitry E, Romelaer C, Aparicio T, Sobhani I.

Aliment Pharmacol Ther. 2009 Aug 15;30(4):414-21. doi: 10.1111/j.1365-2036.2009.04026.x. Epub 2009 Apr 17.

15.

Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.

Patel K, Hernán MA, Williams PL, Seeger JD, McIntosh K, Van Dyke RB, Seage GR 3rd; Pediatric AIDS Clinical Trials Group 219/219C Study Team.

Clin Infect Dis. 2008 Feb 15;46(4):507-15. doi: 10.1086/526524.

PMID:
18199042
16.

HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome?

Bower M, Powles T, Newsom-Davis T, Thirlwell C, Stebbing J, Mandalia S, Nelson M, Gazzard B.

J Acquir Immune Defic Syndr. 2004 Dec 15;37(5):1563-5.

PMID:
15577408
17.

Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy.

Lim ST, Karim R, Tulpule A, Nathwani BN, Levine AM.

J Clin Oncol. 2005 Nov 20;23(33):8477-82. Epub 2005 Oct 17.

PMID:
16230675
18.

Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.

Salzberger B, Hartmann P, Hanses F, Uyanik B, Cornely OA, Wöhrmann A, Fätkenheuer G.

Infection. 2005 Oct;33(5-6):345-9.

PMID:
16258865
19.

Anal carcinomas in HIV-positive patients: high-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy.

Blazy A, Hennequin C, Gornet JM, Furco A, Gérard L, Lémann M, Maylin C.

Dis Colon Rectum. 2005 Jun;48(6):1176-81.

PMID:
15906137
20.

Surgical outcomes in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.

Horberg MA, Hurley LB, Klein DB, Follansbee SE, Quesenberry C, Flamm JA, Green GM, Luu T.

Arch Surg. 2006 Dec;141(12):1238-45.

PMID:
17178967

Supplemental Content

Support Center